Pat Toomey: “Senator Toomey, your bill on NASPER is certainly going to be helpful in helping us with interstate medication diversion.”

I think you have said that you think we still, nevertheless, need to have some kind of outbound investment review mechanism, even though you have just said we already have the authorities to prevent any kind of technology transfer.

If an American venture capital firm, for instance, is investing in a Chinese artificial intelligence company that has ties to the Chinese military, a technology transfer that is associated with that deal that included some kind of…

We have to fix that. Now.

I think that there are a number of ways that you can go about creating a regulatory regime to take account of that risk.